Editorial commentary: antibiotics for treatment of acute respiratory tract infections: decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance

Clin Infect Dis. 2008 Sep 15;47(6):744-6. doi: 10.1086/591149.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Adult
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Drug Resistance, Microbial
  • Humans
  • Respiratory Tract Infections / drug therapy*
  • Risk Assessment

Substances

  • Anti-Bacterial Agents